the importance of better identifying individuals with mgus & the possibility of treating precursors
Published 1 year ago • 744 plays • Length 2:42Download video MP4
Download video MP3
Similar videos
-
5:16
genomic analysis of patients with mgus who progress to myeloma versus those who do not
-
2:19
hematology in focus: mgus with clinical significance
-
5:30
precursor conditions: the importance of screening and early intervention in myeloma
-
5:52
identifying mgus-like phenotype in multiple myeloma and light-chain amyloidosis
-
3:04
identifying high-risk patients with smm & mgus to prevent progression to active myeloma
-
4:04
the future of myeloma treatment and the possibility of cure
-
9:22
myeloma:interpreting test results | bmj learning
-
4:16
the truth about mgus
-
2:01
redefining mgus to better predict progression to active disease
-
2:16
what does the future of mgus look like?
-
1:34:34
declaration of helsinki doh revision process
-
2:47
istopmm analysis results: autoimmune diseases are not associated with mgus
-
2:31
defining precursor conditions in multiple myeloma & strategies to better predict risk of progression
-
1:29
insights into the biology of high-risk myeloma and advances being made in this space
-
1:11
defining precursor states in multiple myeloma
-
11:29
progression and treatment of mgus-smm-mm & epigenetics
-
2:18
the importance of defining precursor states in multiple myeloma
-
1:53
the future of multiple myeloma treatment
-
1:43
an insight into the prevalence of various subtypes of mgus in the istopmm study
-
4:58
overview of the toxicities associated with bispecific agents in multiple myeloma
-
0:55
the significance of cr as an endpoint in frail patients with multiple myeloma
-
2:41
an overview of the latest advances in hematology